benchling.comHealthcare / Healthcare softwareFounded: 2012Funding to Date: $1.27B
Benchling, founded in 2012, is the developer of a biotech platform for biology researchers and research organizations. The cloud-based R&D platform is designed to be an “all-in-one experiment, sample, process, and lab management system”, aiming to make research more accessible, while enabling researchers and scientists to be more collaborative.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/18/2021 | Series F-1 | $11MM | $xx.xx | $6.1B | Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global | |
Price per Share
$xx.xx
Shares Outstanding
336,429
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global
|
||||||
11/18/2021 | Series F | $95MM | $xx.xx | $6.1B | Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global | |
Price per Share
$xx.xx
Shares Outstanding
2,905,528
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global
|
||||||
04/14/2021 | Series E | $200MM | $xx.xx | $4B | Alkeon Capital, Altimeter Capital, Benchmark, Byers Capital, Elad Gil, Iconiq, Lead Edge Capital, Lux Capital, Menlo Ventures, Sequoia Capital, Spark Capital, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,614,020
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alkeon Capital, Altimeter Capital, Benchmark, Byers Capital, Elad Gil, Iconiq, Lead Edge Capital, Lux Capital, Menlo Ventures, Sequoia Capital, Spark Capital, Thrive Capital
|
||||||
05/28/2020 | Series D | $50.55MM | $xx.xx | $850MM | Alkeon, Benchmark, Iconiq Partners, Lux Capital, Menlo Ventures, Spark Capital, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
9,099,735
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alkeon, Benchmark, Iconiq Partners, Lux Capital, Menlo Ventures, Spark Capital, Thrive Capital
|
||||||
07/24/2019 | Series C | $37.03MM | $xx.xx | $409.65MM | Benchmark, Lead Edge Capital, Menlo Ventures, Thrive Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
12,973,581
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Benchmark, Lead Edge Capital, Menlo Ventures, Thrive Capital, Y Combinator
|
||||||
06/14/2018 | Series B | $18.25MM | $xx.xx | $85.05MM | Benchmark, F-Prime Capital, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
28,306,704
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Benchmark, F-Prime Capital, Thrive Capital
|
||||||
10/24/2016 | Series A | $7MM | $xx.xx | $37.94MM | Andreessen Horowitz, David Wallerstein, Thrive Capital, �Ashton Kutcher, �Geoff Ralston, �Matt Huang | |
Price per Share
$xx.xx
Shares Outstanding
15,445,755
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, David Wallerstein, Thrive Capital, �Ashton Kutcher, �Geoff Ralston, �Matt Huang
|
||||||
04/15/2015 | Series Seed | $6.14MM | $xx.xx | $17.54MM | Andreessen Horowitz, Ff Angel, Geoff Ralston, Kevin Mahaffey, Matt Huang, Rock Health, Sv Angel, Thrive Capital, Tim Draper, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
22,212,279
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Ff Angel, Geoff Ralston, Kevin Mahaffey, Matt Huang, Rock Health, Sv Angel, Thrive Capital, Tim Draper, Y Combinator
|